Merics (grey frame)

State support for medtech firms in China far higher than in OECD countries

Financial state support as a share of revenue

Note: Figures are based on 122 Chinese medical technology firms listed on the Shanghai, Shenzhen or Beijing stock exchanges. The state support benchmarks for China and OECD countries are derived from an OECD analysis of state support across 13 sectors and cover the same forms of support calculated for China's medtech firms, namely subsidies, tax benefits, below-market borrowing and below-market equity.
Source: MERICS research based on company and OECD data
© MERICS